Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Seneschal

Showing results (61-70 of 68) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 68 results.
Allergy|April 26, 2017
Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP scoreJ-F Stalder, H Aubert, E Anthoine, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2020
European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitisJ P Thyssen, C Vestergaard, M Deleuran, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 31, 2020
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitisA Wollenberg, C Flohr, D Simon, et al.
The British Journal of Dermatology|August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaA L Bosma, P I Spuls, I Garcia-Doval, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2021
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologicsJ P Thyssen, C Vestergaard, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external expertsJ Ring, M Worm, A Wollenberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 68 results.
Allergy|April 26, 2017
Topical corticosteroid phobia in atopic dermatitis: International feasibility study of the TOPICOP scoreJ-F Stalder, H Aubert, E Anthoine, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 10, 2020
European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitisJ P Thyssen, C Vestergaard, M Deleuran, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 31, 2020
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2) infection and atopic dermatitisA Wollenberg, C Flohr, D Simon, et al.
The British Journal of Dermatology|August 25, 2019
TREatment of ATopic eczema (TREAT) Registry Taskforce: protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczemaA L Bosma, P I Spuls, I Garcia-Doval, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 15, 2021
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologicsJ P Thyssen, C Vestergaard, S Barbarot, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 22, 2021
Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases - practical recommendations. A position statement of ETFAD with external expertsJ Ring, M Worm, A Wollenberg, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 9, 2017
European dermatology forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 2: Scleromyxedema, scleredema and nephrogenic systemic fibrosisR Knobler, P Moinzadeh, N Hunzelmann, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2017
European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromesR Knobler, P Moinzadeh, N Hunzelmann, et al.
Pageof 7